Donald MacAdam's most recent trade in XBiotech Inc was a trade of 37,500 Director Stock Option done . Disclosure was reported to the exchange on June 20, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| XBiotech Inc | Donald MacAdam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 37,500 | 37,500 | - | - | Director Stock Option | |
| XBiotech Inc | Donald MacAdam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 25,000 | 25,000 | - | - | Director Stock Option | |
| XBiotech Inc | Donald MacAdam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option | |
| XBiotech Inc | Donald MacAdam | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.40 per share. | 09 Jul 2021 | 10,000 | 10,000 (0%) | 0% | 4.4 | 44,000 | Common Shares |
| XBiotech Inc | Donald MacAdam | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jul 2021 | 10,000 | 2,500 | - | - | Stock options | |
| XBiotech Inc | Donald MacAdam | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 25,000 | 25,000 | - | - | Stock Option |